deltatrials
Terminated PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT01601184

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

An International, Randomized, Open-label Phase I/II Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Adult Patients With Recurrent or Refractory Medulloblastomas Presenting an Activation of the Sonic Hedgehog (SHH) Pathway

Sponsor: Centre Leon Berard

Updated 10 times since 2017 Last updated: May 20, 2019 Started: Jun 30, 2012 Primary completion: Sep 30, 2017 Completion: Oct 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The number of successes is not reached at the end of first stage of the phase II. The study is stopped.

This PHASE1/PHASE2 trial investigates Activation of the Sonic Hedgehog (SHH) Pathway and Histologically Confirmed Medulloblastoma and is currently terminated or withdrawn. Centre Leon Berard leads this study, which shows 10 recorded versions since 2012 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Oct 2018 · 4 months · monthly snapshotRecruiting~Oct 2018 – ~Jun 2019 · 8 months · monthly snapshotTerminated~Jun 2019 – ~Nov 2020 · 17 months · monthly snapshotTerminated~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotTerminated~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotTerminated~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotTerminated~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotTerminated~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotTerminated~Sep 2025 – present · 11 months · monthly snapshotTerminated

Change History

10 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated PHASE1/PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated PHASE1/PHASE2

    Phase: PHASE1_PHASE2PHASE1/PHASE2

  4. Dec 2021 — Jul 2024 [monthly]

    Terminated PHASE1_PHASE2

  5. Jan 2021 — Dec 2021 [monthly]

    Terminated PHASE1_PHASE2

Show 5 earlier versions
  1. Nov 2020 — Jan 2021 [monthly]

    Terminated PHASE1_PHASE2

  2. Jun 2019 — Nov 2020 [monthly]

    Terminated PHASE1_PHASE2

  3. Oct 2018 — Jun 2019 [monthly]

    Terminated PHASE1_PHASE2

    Status: RecruitingTerminated

  4. Jun 2018 — Oct 2018 [monthly]

    Recruiting PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Jun 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Leon Berard
  • Ministry of Health, France
Data source: Centre Leon Berard

For direct contact, visit the study record on ClinicalTrials.gov .